Clinical Trial Update: A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

View source ↗

Summary

A Novartis-sponsored mobile app-based study in the United States aims to evaluate disease burden and treatment patterns in Immunoglobulin A Nephropathy and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Immunoglobulin A Nephropathy | Status: RECRUITING